adaptive radiotherapy in prostate cancer patients

Dosimetric and radiobiologic assessment of adaptive radiotherapy by using contour based dose painting method drived from multi-parametric MRI (mpMRI) in prostate cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181006041257N1

Enrollment

Registered

2019-10-23

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer. Dysplasia of prostate

Interventions

Intervention 1: Dosimetric and radiobiologic assessment by using contour based dose painting method drived from multi-parametric MRI. Intervention 2: Control group: intensity-modulated radiotherapy f

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with localised high-risk prostate carcinoma

Exclusion criteria

Exclusion criteria: previousprostatectomy general contraindications for MRI (i.e. cardiac pacemaker,metal implants )

Design outcomes

Primary

Measure	Time frame
Tumor volume. Timepoint: Before treatment and four months after radiotherapy. Method of measurement: diffusion weighted Images (DWI).;ADC. Timepoint: Before treatment and four months after radiotherapy. Method of measurement: diffusion weighted Images (DWI).;Prostate-specific antigen (PSA). Timepoint: Before treatment and four months after radiotherapy. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBijan Hashemi

The University of tarbiat modares

bhashemi@modares.ac.ir+98 21 8288 4131

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 14, 2026